Cargando…
Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer
BACKGROUND: To develop a novel therapeutic strategy for human pancreatic cancer using a midkine promoter-based conditionally replicating adenovirus. METHODS: We examined midkine mRNA expression and midkine protein expression by seven human pancreatic cancer cell lines (AsPC-1, BxPC-3, CFPAC-1, HPAC,...
Autores principales: | Toyoda, Eiji, Doi, Ryuichiro, Kami, Kazuhiro, Mori, Tomohiko, Ito, Daisuke, Koizumi, Masayuki, Kida, Atsushi, Nagai, Kazuyuki, Ito, Tatsuo, Masui, Toshihiko, Wada, Michihiko, Tagawa, Masatoshi, Uemoto, Shinji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529268/ https://www.ncbi.nlm.nih.gov/pubmed/18717994 http://dx.doi.org/10.1186/1756-9966-27-30 |
Ejemplares similares
-
Midkine in Inflammation
por: Weckbach, Ludwig T., et al.
Publicado: (2011) -
Prognostic value of metastin expression in human pancreatic cancer
por: Nagai, Kazuyuki, et al.
Publicado: (2009) -
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin
por: Ak, Guntulu, et al.
Publicado: (2017) -
Midkine’s Role in Cardiac Pathology
por: Woulfe, Kathleen C., et al.
Publicado: (2017) -
The expression and function of midkine in the vertebrate retina
por: Gramage, E, et al.
Publicado: (2014)